Therefore, for the clinical applications, the dosage of GLP‐1R agonists needs to be carefully adjusted to balance benefit and side effects, nevertheless this strategy would be a good option for the patients with concomitant diabetes or overweight. The gene discussed is GLP1R; the disease is diabetes mellitus.